A股公司沉痛公告：80岁创始人逝世，生前曾任清华大学教授

Core Viewpoint - The passing of Cui Fuzhai, a key figure in Aojing Medical, is a significant event for the company, but it is stated that his death will not impact the company's operations or management stability due to the established core technical team [1][2]. Group 1: Company Background - Aojing Medical was founded in 2004 by Cui Fuzhai and his research team, focusing on biomimetic mineralization technology, leading to a series of patents and industrialization of products such as mineralized collagen artificial bone powder and membranes [3]. - The company is dedicated to the research, production, and sales of implantable medical devices for tissue regeneration and repair, achieving significant clinical applications in orthopedics, dentistry, and neurosurgery with over one million clinical uses of its mineralized collagen products [3]. Group 2: Contributions of Cui Fuzhai - Cui Fuzhai held multiple academic and professional roles, including professor and doctoral supervisor at Tsinghua University, and was recognized as a fellow by various international engineering societies [2]. - His research focused on the mechanisms of natural mineralization in bones and teeth, and he made significant contributions to the development of biomaterials, earning national awards for his work [2]. Group 3: Company Stability - Aojing Medical reassured stakeholders that Cui Fuzhai's role as Chief Scientist does not affect the management structure, as the company has a stable core technical team in place [1].